Shares of Zydus Lifesciences Ltd ended at ₹887.95, up by ₹16.15, or 1.85%, on the BSE.

Resham Jain, Fund Manager at DSP Mutual Fund said that the fund is actively buying stocks where earnings remain stable despite the market slowdown.

Citi wrote in its note that it expects a strong launch momentum in the US for the drug-maker and continued traction in its non-US business.…

At the close, the Sensex surged 740 points to finish at 73,730, while the Nifty gained 255 points, closing at 22,337. This marked a nearly…

NSE MD & CEO Ashishkumar Chauhan says GIFT IFSC can replicate Hong Kong’s role for China, setting a 12-year timeline for global dominance with 40-50…

Brokerage firm Goldman Sachs, cited a strong order pipeline, particularly in high-voltage direct current (HVDC) projects, as a key driver of future growth. Reflecting its…

ICRA also wrote in its note that it has noted a deterioration in the financial flexibility of the company with an increase in promoter’s share…

Satyam Panday, Chief US & Canada Economist at S&P Global Ratings, expects US GDP growth to slow to 1.5% in the first quarter, down from…

While the rupee has strengthened, it lags behind some of its regional peers.

The north America class 8 truck orders declined 34% to 17,000 units from the previous year’s 25,700 units and were down 29% from the previous…